Quick Answer
Elevance Health, Inc. reported Total Revenue of $199.13 billion for the year ending 2025.
- Elevance Health, Inc. showed an increase of +12.5% in Total Revenue from 2024 to 2025.
- This data is from Elevance Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 6, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $18.47 billion | Q3 2014: $18.56 billion | Q4 2014: $18.98 billion | Q1 2015: $19.05 billion | Q2 2015: $20.02 billion | Q3 2015: $19.90 billion | Q4 2015: $20.19 billion | Q1 2016: $20.29 billion | Q2 2016: $21.46 billion | Q3 2016: $21.40 billion | Q4 2016: $21.71 billion | Q1 2017: $22.53 billion | Q2 2017: $22.41 billion | Q3 2017: $22.43 billion | Q4 2017: $22.68 billion | Q1 2018: $22.54 billion | Q2 2018: $22.94 billion | Q3 2018: $23.25 billion | Q4 2018: $23.37 billion | Q1 2019: $24.67 billion | Q2 2019: $25.47 billion | Q3 2019: $26.67 billion | Q4 2019: $27.41 billion | Q1 2020: $29.62 billion | Q2 2020: $29.26 billion | Q3 2020: $31.16 billion | Q4 2020: $31.82 billion | Q1 2021: $32.39 billion | Q2 2021: $33.85 billion | Q3 2021: $35.82 billion | Q1 2022: $38.10 billion | Q2 2022: $38.63 billion | Q3 2022: $39.94 billion | Q1 2023: $42.17 billion | Q2 2023: $43.67 billion | Q3 2023: $42.85 billion | Q1 2024: $42.58 billion | Q2 2024: $43.89 billion | Q3 2024: $45.11 billion | Q1 2025: $48.89 billion | Q2 2025: $49.78 billion | Q3 2025: $50.71 billion.
- Over the full 18 years of available data (2008 to 2025), Elevance Health, Inc.'s Total Revenue has grown by 225.1%.
- Historical annual values: Fiscal year 2025: $199.13 billion | Fiscal year 2024: $177.01 billion | Fiscal year 2023: $171.34 billion | Fiscal year 2022: $156.60 billion | Fiscal year 2021: $138.64 billion | Fiscal year 2020: $121.87 billion | Fiscal year 2019: $104.21 billion | Fiscal year 2018: $92.11 billion | Fiscal year 2017: $90.04 billion | Fiscal year 2016: $84.86 billion | Fiscal year 2015: $79.16 billion | Fiscal year 2014: $73.87 billion | Fiscal year 2013: $71.02 billion | Fiscal year 2012: $61.50 billion | Fiscal year 2011: $60.71 billion | Fiscal year 2010: $58.70 billion | Fiscal year 2009: $64.94 billion | Fiscal year 2008: $61.25 billion.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: